The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

In animal studies, brain tumors nearly disappeared when an experimental drug, MT-125, was given as a combo with an oncology drug that otherwise does not work on aggressive glioblastoma. The U.S. Food ...

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how ...

Food allergies affect up to 10% of the population in the USA and have been increasing in prevalence over the last 2–3 ...

The Oxfordshire, England-based mathematical modelling company said it has inked an 18-month contract worth GBP98,600 with an existing, unnamed client that will see it apply PK/PD modelling and ...

A scientific message will not resonate unless viewers have clear reason to care about the issue and, more importantly, to ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced publication of the ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Given the variability between labs and the unique nature of R&D work, custom, niche AI tools are going to become much more ...

The tech giant poached several top Google researchers to help build a powerful AI tool that can diagnose patients and ...